Search results
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 3 hours agoVir Biotechnology (VIR) delivered earnings and revenue surprises of 51.52% and 250.82%,...
Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
GuruFocus.com via Yahoo Finance· 3 hours agoLiquidity: Cash, cash equivalents, and marketable securities stood at $107.2 million as of March 31,...
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 11 hours agoAdverum Biotechnologies (ADVM) possesses the right combination of the two key ingredients for a...
Earnings call: Genmab reports strong Q1 growth, plans ProfoundBio acquisition By Investing.com
Investing.com· 1 hour agoGenmab A/S (NASDAQ:GMAB), the Danish biotechnology company, reported robust financial results in its...
We're Hopeful That Nautilus Biotechnology (NASDAQ:NAUT) Will Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 13 hours agoBut the harsh reality is that very many loss making companies burn through all their cash and go...
Monte Rosa Therapeutics announces CSO transition By Investing.com
Investing.com· 2 hours agoMonte Rosa Therapeutics, Inc. (NASDAQ:GLUE), a biotechnology firm engaged in the development of...
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoNautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript April 30, 2024 Nautilus ...
Amgen First-Quarter Profit Dips 1%, Revenue Rises 22%
US News & World Report· 5 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Vor Bio appoints new board member with oncology expertise By Investing.com
Investing.com· 2 hours agoVor Bio (NASDAQ:VOR), a biotechnology firm specializing in cell and genome engineering, announced...
BXP, Biotech Company Spar Over Kendall Square Site
The Real Deal· 6 hours agoA dispute between a biotechnology company and a prominent developer is bubbling up in one of the country’s top life sciences markets. Brammer Bio filed a...